Japan

Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Yahoo
Amgen
Daiichi Sankyo
Japan
biosimilars
Flag link:
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Yahoo
Regeneron
Sanofi
Praluent
Japan
PCSK9 inhibitors
Flag link:
Daiichi snaps up Japanese rights to CVD stem-cell therapy
Daiichi snaps up Japanese rights to CVD stem-cell therapy
BioPharma Dive
Daiichi Sankyo
Japan
stem cells
Heartcel
Cell Therapy Group
Flag link:
Lilly shines in Japan in Q1, but CEO warns price cuts too deep
Lilly shines in Japan in Q1, but CEO warns price cuts too deep
Fierce Pharma
Eli Lilly
Japan
drug pricing
Pharma CEOs
John Lechleiter
Flag link:
Novo makes inroads in Japan with long-acting insulin Tresiba
Novo makes inroads in Japan with long-acting insulin Tresiba
Fierce Pharma
Japan
Novo Nordisk
diabetes
insulin
Tresiba
Flag link:
Drugmakers say Japan R&D spending at risk after government forces price cuts
Drugmakers say Japan R&D spending at risk after government forces price cuts
Yahoo/Reuters
Japan
R&D
Gilead Sciences
Sovaldi
Flag link:
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
Yahoo
Takeda
Teva Pharmaceutical
Japan
Teva Takeda Yakuhin Ltd.
Flag link:
Sun Pharma expands presence in Japan with $293 million Novartis deal
Sun Pharma expands presence in Japan with $293 million Novartis deal
BioPharma Dive
Sun Pharma
Japan
Novartis
Flag link:
This $150,000 Cancer Treatment Saved a Pharma Company
This $150,000 Cancer Treatment Saved a Pharma Company
Bloomberg
Ono Pharmaceutical
Opdivo
Bristol-Myers Squibb
Japan
Flag link:
Takeda-Teva JV 'could be a trendsetter' as Japan pushes for generics: analyst
Takeda-Teva JV 'could be a trendsetter' as Japan pushes for generics: analyst
Fierce Pharma
Takeda
Teva Pharmaceutical
Japan
generics
Flag link:
Bristol-Myers, Pfizer and Eisai bet big biobucks on the Japanese market
Bristol-Myers, Pfizer and Eisai bet big biobucks on the Japanese market
Fierce Biotech
Japan
Bristol-Myers Squibb
Pfizer
Eisai
Flag link:
Amgen's Repatha wins first PCSK9 OK in Japan
Amgen's Repatha wins first PCSK9 OK in Japan
Fierce Pharma
Amgen
Repatha
PCSK9 inhibitors
Japan
Flag link:
Takeda Provides Further Information about Its New Business Venture with Teva
Takeda Provides Further Information about Its New Business Venture with Teva
Yahoo
Takeda
Teva Pharmaceutical
generics
Japan
Flag link:
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
Yahoo
Teva
Takeda
Japan
Flag link:
New medicine for house dust mite allergic rhinitis now available in Japan
New medicine for house dust mite allergic rhinitis now available in Japan
Yahoo
allergic rhinitis
Japan
dust mites
Miticure
ALK
Merck
Flag link:
Gilead Sciences, Inc Not Likely To Go For Large M&A: Maxim Group
Gilead Sciences, Inc Not Likely To Go For Large M&A: Maxim Group
Bidness, ETC
Gilead Sciences
M&A
Japan
hepatitis C
Flag link:
Intercept's much-hyped NASH drug misses the mark in Phase II
Intercept's much-hyped NASH drug misses the mark in Phase II
Fierce Biotech
Intercept Pharmaceuticals
NASH
Sumitomo Dainippon
Japan
OCA
Flag link:
Merck bags Japanese approval for a weekly diabetes drug
Merck bags Japanese approval for a weekly diabetes drug
Fierce Biotech
Merck
Japan
diabetes
omarigliptin
Januvia
Flag link:
Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan
Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan
Yahoo
GSK
Theravance
COPD
Japan
Relvar Ellipta
Flag link:
Drug launch in Japan to trigger $20M payment to Endo
Drug launch in Japan to trigger $20M payment to Endo
Bizjournals.com
Japan
drug launches
Endo International
Xiaflex
Flag link: